DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
Vastert SJ, de Jager W, Noordman BJ. et al.
Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.
Arthritis & rheumatology (Hoboken, NJ) 2014;
66 (04) 1034-1043.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.